Arrowhead Pharmaceuticals, Inc. (ARWR)
58.56
-2.17
(-3.57%)
USD |
NASDAQ |
Oct 13, 14:59
Arrowhead Pharmaceuticals Total Return Level : 60.73 for Oct. 12, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 12, 2026 | 60.73 |
| October 09, 2026 | 62.75 |
| October 08, 2026 | 60.74 |
| October 07, 2026 | 61.48 |
| October 06, 2026 | 61.54 |
| October 05, 2026 | 62.35 |
| October 02, 2026 | 64.19 |
| October 01, 2026 | 64.79 |
| September 30, 2026 | 65.45 |
| September 29, 2026 | 66.25 |
| September 28, 2026 | 65.46 |
| September 25, 2026 | 65.92 |
| September 24, 2026 | 66.07 |
| September 23, 2026 | 66.96 |
| September 22, 2026 | 71.86 |
| September 21, 2026 | 68.79 |
| September 18, 2026 | 66.48 |
| September 17, 2026 | 67.74 |
| September 16, 2026 | 65.79 |
| September 15, 2026 | 70.67 |
| September 14, 2026 | 80.67 |
| September 11, 2026 | 82.85 |
| September 10, 2026 | 82.76 |
| September 09, 2026 | 82.63 |
| September 08, 2026 | 85.11 |
| Date | Value |
|---|---|
| September 04, 2026 | 86.34 |
| September 03, 2026 | 86.49 |
| September 02, 2026 | 85.37 |
| September 01, 2026 | 82.74 |
| August 31, 2026 | 82.39 |
| August 28, 2026 | 84.91 |
| August 27, 2026 | 88.59 |
| August 26, 2026 | 89.12 |
| August 25, 2026 | 88.88 |
| August 24, 2026 | 86.73 |
| August 21, 2026 | 87.11 |
| August 20, 2026 | 87.47 |
| August 19, 2026 | 89.41 |
| August 18, 2026 | 87.90 |
| August 17, 2026 | 88.70 |
| August 14, 2026 | 86.64 |
| August 13, 2026 | 85.59 |
| August 12, 2026 | 87.25 |
| August 11, 2026 | 89.24 |
| August 10, 2026 | 88.33 |
| August 07, 2026 | 87.65 |
| August 06, 2026 | 85.83 |
| August 05, 2026 | 86.91 |
| August 04, 2026 | 89.59 |
| August 03, 2026 | 86.01 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Moderna, Inc. | 213.74 |
| Sarepta Therapeutics, Inc. | 17.44 |
| Revolution Medicines, Inc. | 193.95 |
| Intellia Therapeutics, Inc. | 12.58 |
| Denali Therapeutics, Inc. | 18.95 |